FDA Adverse Event Reports and SBA – OXBRYTA (Voxelotor)

FDA Adverse Event Reports and SBA – OXBRYTA (Voxelotor)

Regular price $69.00 USD
Regular price Sale price $69.00 USD
Sale Sold out
Original Request: 1) All Adverse Event Reporting data for OXBRYTA (voxelotor) 2) Summary basis of approval for application for OXBRYTA (voxelotor)
  • Status: Pending Fast-Track Request
  • Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity

NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.

View full details